MedinCell S.A. (EPA:MEDCL)

MedinCell Balance Sheet

Financials in millions EUR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	31.64	19.46	6.47	24.62	47.1	12.38
Short-Term Investments	7.22	-	0	1.97	2.79	0.01
Cash & Short-Term Investments	38.85	19.46	6.47	26.59	49.88	12.39
Cash Growth	45.09%	200.77%	-75.67%	-46.69%	302.63%	-41.99%
Accounts Receivable	2.82	2.25	2.09	0.8	0.88	0.62
Other Receivables	4.32	4.46	10.18	4.88	3.71	3.76
Receivables	7.14	6.71	12.27	5.68	4.59	4.38
Prepaid Expenses	0.88	0.97	0.74	1.14	0.87	0.59
Other Current Assets	0.88	0.12	0.08	0.67	0.99	0.38
Total Current Assets	47.75	27.26	19.57	34.07	56.33	17.73
Property, Plant & Equipment	5.17	5.43	6.37	7.03	3.85	4.05
Long-Term Investments	2.76	1.27	0.9	1.27	1.08	0.59
Other Intangible Assets	2.62	2.45	1.93	1.67	1.49	1.51
Other Long-Term Assets	0.56	0.54	0.57	0.26	0.86	3.43
Total Assets	58.86	36.95	29.34	44.3	63.61	27.31
Accounts Payable	2.37	1.85	4.18	2.98	2.96	3.14
Accrued Expenses	3.73	3.15	2.48	1.42	1.96	1.05
Current Portion of Long-Term Debt	6.89	5.52	42.81	27.76	3.18	1.46
Current Portion of Leases	0.66	0.64	0.64	0.58	0.39	0.32
Current Unearned Revenue	18.81	5.18	5.78	5.29	4.85	0.4
Other Current Liabilities	0.21	0.13	1.13	0.21	0.27	0.23
Total Current Liabilities	32.66	16.47	57.03	38.24	13.6	6.6
Long-Term Debt	59.47	56.29	11.71	16.25	39.07	31.28
Long-Term Leases	2.18	2.26	2.54	2.9	0.71	0.78
Long-Term Unearned Revenue	-	-	-	-	0.84	4.21
Other Long-Term Liabilities	18.17	2.4	0	0.02	0.02	-
Total Liabilities	112.89	77.77	71.63	57.67	54.48	43.27
Common Stock	0.29	0.29	0.25	0.25	0.25	0.2
Additional Paid-In Capital	31.16	31.01	7.42	6.91	75.15	33.19
Retained Earnings	-14.57	-25.04	-32.01	-24.81	-18.99	-23.92
Comprehensive Income & Other	-70.91	-47.09	-17.95	4.27	-47.28	-25.43
Total Common Equity	-54.03	-40.82	-42.29	-13.37	9.13	-15.96
Shareholders' Equity	-54.03	-40.82	-42.29	-13.37	9.13	-15.96
Total Liabilities & Equity	58.86	36.95	29.34	44.3	63.61	27.31
Total Debt	69.19	64.71	57.71	47.49	43.35	33.84
Net Cash (Debt)	-30.34	-45.25	-51.24	-20.9	6.54	-21.45
Net Cash Per Share	-1.04	-1.59	-2.03	-0.84	0.30	-1.07
Filing Date Shares Outstanding	29.11	29.09	28.71	25.11	24.68	20.11
Total Common Shares Outstanding	29.11	29.07	25.28	25.11	24.68	20.11
Working Capital	15.1	10.79	-37.46	-4.17	42.73	11.13
Book Value Per Share	-1.86	-1.40	-1.67	-0.53	0.37	-0.79
Tangible Book Value	-56.65	-43.27	-44.22	-15.04	7.64	-17.47
Tangible Book Value Per Share	-1.95	-1.49	-1.75	-0.60	0.31	-0.87
Machinery	7.76	7.64	7.36	7.14	5.69	5.07
Construction In Progress	0.11	0.04	0.26	0.13	0.05	0.03

Updated Dec 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.